Clinical Trials Logo

Filter by:
NCT ID: NCT03277482 Terminated - Clinical trials for Recurrent Ovarian Carcinoma

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Start date: June 1, 2018
Phase: Phase 1
Study type: Interventional

This research study is evaluating the safety and effectiveness of 2 immunotherapy drugs in combination with radiation therapy as a possible treatment for recurrent or metastatic gynecologic cancer. The names of the immunotherapy drugs involved in this study are: - Durvalumab - Tremelimumab

NCT ID: NCT03277352 Terminated - Metastatic Cancer Clinical Trials

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Start date: November 21, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies.

NCT ID: NCT03277209 Terminated - Pancreas Cancer Clinical Trials

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Start date: July 25, 2017
Phase: Phase 1
Study type: Interventional

A dose escalation trial to assess the safety of plerixafor in patients with advanced pancreatic, high grade serous ovarian and colorectal cancer. To identify the proof of mechanism, by demonstrating alterations in T-cell tumour distribution, ideally associated with loss of tumour cells, measured by immunostaining, and changes in FDG uptake.

NCT ID: NCT03277183 Terminated - Anemia Clinical Trials

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

Start date: November 2, 2017
Phase: Phase 4
Study type: Interventional

Although several large well designed clinical trials have shown that erythropoietin which is commonly used to treat anemia associated with kidney disease, increases the risk of stroke and heart disease, the mechanism for this increased risk is unknown. The investigators' preliminary studies show that the adverse effects of erythropoietin are from activation of the heterodimeric erythropoietin/ beta common receptor which only occurs with high doses of erythropoietin. The investigators propose a clinical trial of 120 patients assigned to low doses of erythropoietin given more frequently or the same cumulative dose of erythropoietin administered as a high dose once every two weeks and assess effects on the beta common receptor activation, inflammation and vascular disease as evidence by MRI of the carotid arteries.

NCT ID: NCT03276741 Terminated - Satisfaction Clinical Trials

Oral Intake During Labor

Start date: September 29, 2017
Phase: N/A
Study type: Interventional

A randomized clinical trial (RCT) to evaluate the impact of unrestricted low fat, low residue oral intake during labor on maternal and neonatal outcomes as well as maternal satisfaction.

NCT ID: NCT03276728 Terminated - Heart Failure Clinical Trials

Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients

Start date: August 12, 2016
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of ascending single (Part A) and ascending multiple (Part B) doses of AMG 986 in healthy adults and of ascending multiple oral doses of AMG 986 in heart failure patients (Part C).

NCT ID: NCT03276208 Terminated - Pregnancy Related Clinical Trials

Pregnancy, Mindfulness, and Massage

Start date: November 27, 2017
Phase: N/A
Study type: Interventional

This trial will examine the contribution of massage therapy and mindfulness to tobacco-smoking women in the third trimester of pregnancy.

NCT ID: NCT03276026 Terminated - Clinical trials for Postoperative Nausea and Vomiting

A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

Start date: February 12, 2018
Phase: Phase 4
Study type: Interventional

The investigators will track bariatric patients who received sugammadex versus neostigmine in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting / hypoxia episodes.

NCT ID: NCT03275753 Terminated - Clinical trials for Age Related Macular Degeneration

Visual Function Tests in Age-related Macular Degeneration

Start date: September 21, 2017
Phase:
Study type: Observational

The goal of this study is to assess a battery of visual function tests in subjects with non-exudative age-related macular degeneration

NCT ID: NCT03275740 Terminated - Healthy Clinical Trials

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Start date: July 17, 2017
Phase: Phase 1
Study type: Interventional

This phase 1 single ascending dose study will provide a first in human assessment of safety and tolerability of PF-06755347 in healthy adult males as well as adult males and females with Immune Thrombocytopenia (ITP). Pharmacokinetics and pharmacodynamics will also be evaluated.